Results 161 to 170 of about 482,990 (203)
Some of the next articles are maybe not open access.
2021
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +1 more source
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +1 more source
Chronic hepatic prophyria type C
Klinische Wochenschrift, 1971In four patients with liver disease (fatty liver, fibrosis, and cirrhosis) the concentrations of uroporphyrin and heptacarboxylic porphyrin in the liver were found to be considerably elevated (up to 90 µg/g). The patients also excreted increased amounts of porphyrin with the urine (0.5–1 mg/l), although cutaneous symptoms were not present.
M, Doss +11 more
openaire +2 more sources
THERAPY FOR CHRONIC HEPATITIS C
Gastroenterology Clinics of North America, 1994Hepatitis C is the silent epidemic of the 1970s and 1980s. Interferon alfa is currently the only effective treatment. Enthusiasm for interferon therapy must be tempered because advanced disease usually requires years or even decades to develop and does not occur in all patients.
G L, Davis, J Y, Lau, H L, Lim
openaire +2 more sources
Management of Chronic Hepatitis C
Journal of the American Academy of Nurse Practitioners, 2001One purpose of the Clinical Practice Guideline column is to increase the awareness of the broad availability of existing guidelines and recommendations on various health topics. The hepatitis C virus (HCV) currently accounts for 20% to 40% of acute viral hepatitis, 60% to 80% of chronic hepatitis, and 20% to 30% of cirrhosis, end‐stage liver disease ...
Mary Jo Goolsby, James Blackwell
openaire +2 more sources
BMJ clinical evidence, 2018
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic overview and aimed to answer the following clinical questions: What are the effects of interferon-free treatments in treatment-naïve people with chronic hepatitis C ...
Alan Hoi Lun, Yau +2 more
openaire +1 more source
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic overview and aimed to answer the following clinical questions: What are the effects of interferon-free treatments in treatment-naïve people with chronic hepatitis C ...
Alan Hoi Lun, Yau +2 more
openaire +1 more source
Aminoadamantanes for chronic hepatitis C
Cochrane Database of Systematic Reviews, 2012Around 3% of the world's population (approximately 160 million people) are chronically infected with hepatitis C virus. The proportion of infected people who develop clinical symptoms varies between 5% and 40%. Combination therapy with pegylated interferon-alpha plus ribavirin eradicates the virus from the blood six months after treatment (sustained ...
Lamers, M.H. +5 more
openaire +3 more sources
Nitazoxanide for chronic hepatitis C
Cochrane Database of Systematic Reviews, 2014Hepatitis C infection is a disease of the liver caused by the hepatitis C virus. The estimated number of chronically infected people with hepatitis C virus worldwide is about 150 million people. Every year, another three to four million people acquire the infection. Chronic hepatitis C is a leading cause of liver-related mortality and morbidity.
Kristiana, Nikolova +3 more
openaire +2 more sources
Adiponectin in chronic hepatitis C
Clinical Journal of Gastroenterology, 2013White adipose tissue has been increasingly recognized as an important endocrine organ that secretes a number of biologically active adipokines. Adiponectin, one of the major adipokines, possesses anti-inflammatory and insulin-sensitizing properties, and its serum levels typically decline with increasing body weight.
Toru, Arano +3 more
openaire +2 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +2 more sources
BMJ clinical evidence, 2007
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions in treatment-naïve people with chronic hepatitis C infection, but ...
Abdul, Mohsen, Suzanne, Norris
openaire +3 more sources
About 60% to 85% of people infected with hepatitis C virus will go on to develop chronic hepatitis C, which is now believed to affect 3% of the world's population.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions in treatment-naïve people with chronic hepatitis C infection, but ...
Abdul, Mohsen, Suzanne, Norris
openaire +3 more sources